Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

masimo corp. - MASI

MASI

Close Chg Chg %
164.95 2.45 1.48%

Open Market

167.40

+2.45 (1.48%)

Volume: 85.88K

Last Updated:

Nov 21, 2024, 11:25 AM EDT

Trade Now

Company Overview: masimo corp. - MASI

MASI Key Data

Open

$164.95

 Day Range

163.80 - 168.40

52 Week Range

91.60 - 173.90

 Market Cap

$8.83B

Shares Outstanding

53.54M

 Public Float

49.24M

Beta

0.97

 Rev. Per Employee

N/A

P/E Ratio

113.21

 EPS

$1.49

Yield

0.00%

 Dividend

$1.00

EX-DIVIDEND DATE

Nov 23, 2012

 SHORT INTEREST

N/A

AVERAGE VOLUME

626.77K

  

MASI Performance

1 Week
 
 2.41%
 
1 Month
 
 18.39%
 
3 Months
 
 37.53%
 
1 Year
 
 75.35%
 
5 Years
 
 7.56%
 

MASI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About masimo corp. - MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

MASI At a Glance

Masimo Corp.
52 Discovery
Irvine, California 92618
Phone 1-949-297-7000 Revenue 2.05B
Industry Medical Specialties Net Income 81.50M
Sector Health Technology 2023 Sales Growth 0.604%
Fiscal Year-end 12 / 2024 Employees 9,000
View SEC Filings

MASI Valuation

P/E Current 113.212
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 77.803
Price to Sales Ratio 3.096
Price to Book Ratio 4.535
Price to Cash Flow Ratio 67.386
Enterprise Value to EBITDA 27.209
Enterprise Value to Sales 3.489
Total Debt to Enterprise Value 0.136

MASI Efficiency

Revenue/Employee 227,566.667
Income Per Employee 9,055.556
Receivables Turnover 4.865
Total Asset Turnover 0.655

MASI Liquidity

Current Ratio 2.185
Quick Ratio 1.218
Cash Ratio 0.294

MASI Profitability

Gross Margin 48.997
Operating Margin 8.022
Pretax Margin 4.302
Net Margin 3.979
Return on Assets 2.607
Return on Equity 6.029
Return on Total Capital 3.491
Return on Invested Capital 3.531

MASI Capital Structure

Total Debt to Total Equity 71.073
Total Debt to Total Capital 41.545
Total Debt to Total Assets 31.892
Long-Term Debt to Equity 67.226
Long-Term Debt to Total Capital 39.297
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Masimo Corp. - MASI

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
1.14B 1.24B 2.04B 2.05B
Sales Growth
+21.96% +8.34% +64.29% +0.60%
Cost of Goods Sold (COGS) incl D&A
400.68M 430.81M 977.00M 1.04B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
29.30M 36.12M 136.10M 98.30M
Depreciation
21.80M 25.82M 96.30M 43.90M
Amortization of Intangibles
7.50M 10.30M 39.80M 54.40M
COGS Growth
+29.81% +7.52% +126.78% +6.92%
Gross Income
743.07M 808.35M 1.06B 1.00B
Gross Income Growth
+18.10% +8.79% +30.98% -5.22%
Gross Profit Margin
+64.97% +65.23% +52.01% +49.00%
2020 2021 2022 2023 5-year trend
SG&A Expense
487.72M 532.52M 832.20M 839.20M
Research & Development
118.66M 137.23M 191.40M 175.20M
Other SG&A
369.06M 395.29M 640.80M 664.00M
SGA Growth
+19.55% +9.19% +56.27% +0.84%
Other Operating Expense
- - - -
-
Unusual Expense
- (474.00K) 16.60M 27.80M
EBIT after Unusual Expense
255.82M 275.82M 210.00M 136.50M
Non Operating Income/Expense
8.25M (1.09M) 9.10M 1.90M
Non-Operating Interest Income
5.53M 936.00K 1.80M 3.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
338.00K 355.00K 25.70M 50.30M
Interest Expense Growth
+3.05% +5.03% +7,139.44% +95.72%
Gross Interest Expense
338.00K 355.00K 25.70M 50.30M
Interest Capitalized
- - - -
-
Pretax Income
263.74M 274.38M 193.40M 88.10M
Pretax Income Growth
+12.63% +4.04% -29.51% -54.45%
Pretax Margin
+23.06% +22.14% +9.50% +4.30%
Income Tax
23.45M 44.73M 49.90M 6.60M
Income Tax - Current - Domestic
20.34M 45.23M 54.80M 18.50M
Income Tax - Current - Foreign
8.07M 14.58M 34.40M 23.70M
Income Tax - Deferred - Domestic
(4.84M) (10.94M) (29.20M) (21.50M)
Income Tax - Deferred - Foreign
(127.00K) (4.15M) (10.10M) (14.10M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
240.28M 229.65M 143.50M 81.50M
Minority Interest Expense
- - - (20.00K)
-
Net Income
240.30M 229.65M 143.50M 81.50M
Net Income Growth
+22.47% -4.43% -37.51% -43.21%
Net Margin Growth
+21.01% +18.53% +7.05% +3.98%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
240.30M 229.65M 143.50M 81.50M
Preferred Dividends
- - - -
-
Net Income Available to Common
240.30M 229.65M 143.50M 81.50M
EPS (Basic)
4.3931 4.1628 2.6772 1.5436
EPS (Basic) Growth
+19.63% -5.24% -35.69% -42.34%
Basic Shares Outstanding
54.70M 55.17M 53.60M 52.80M
EPS (Diluted)
4.1405 3.9813 2.5996 1.5065
EPS (Diluted) Growth
+20.49% -3.84% -34.70% -42.05%
Diluted Shares Outstanding
58.04M 57.68M 55.20M 54.10M
EBITDA
284.65M 311.94M 362.70M 262.60M
EBITDA Growth
+15.85% +9.59% +16.27% -27.60%
EBITDA Margin
+24.89% +25.17% +17.82% +12.82%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 156.667
Number of Ratings 11 Current Quarters Estimate 1.42
FY Report Date 12 / 2024 Current Year's Estimate 4.028
Last Quarter’s Earnings 0.98 Median PE on CY Estimate N/A
Year Ago Earnings 3.79 Next Fiscal Year Estimate 4.642
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 8 9 9
Mean Estimate 1.42 1.02 4.03 4.64
High Estimates 1.44 1.19 4.05 5.04
Low Estimate 1.38 0.87 3.99 4.34
Coefficient of Variance 1.32 9.48 0.43 5.08

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 1 0 2
HOLD 5 6 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Masimo Corp. - MASI

Date Name Shares Transaction Value
May 6, 2024 Craig B. Reynolds Director 17,406 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $23.04 per share 401,034.24
May 6, 2024 Craig B. Reynolds Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 2, 2024 Craig B. Reynolds Director 10,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 4, 2024 Joe E. Kiani CEO and Chairman of the Board; Director 57,382 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Bilal Muhsin Chief Operating Officer 17,270 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.7 per share 2,222,649.00
Mar 4, 2024 Bilal Muhsin Chief Operating Officer 18,015 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Micah Young EVP & Chief Financial Officer 30,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Micah Young EVP & Chief Financial Officer 11,954 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Micah Young EVP & Chief Financial Officer 10,536 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.7 per share 1,355,983.20
Mar 4, 2024 Micah Young EVP & Chief Financial Officer 10,924 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Tao L. Levy EVP, BUS DEV 30,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Tao L. Levy EVP, BUS DEV 7,390 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Tao L. Levy EVP, BUS DEV 11,208 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.7 per share 1,442,469.60
Mar 4, 2024 Tao L. Levy EVP, BUS DEV 11,609 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Blair Tripodi COO, Consumer Division 30,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Joe E. Kiani CEO and Chairman of the Board; Director 372,176 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.7 per share 47,899,051.20
Mar 4, 2024 Joe E. Kiani CEO and Chairman of the Board; Director 376,105 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Thomas Samuel McClenahan EVP, GEN COUNSEL & CORP SEC 30,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Thomas Samuel McClenahan EVP, GEN COUNSEL & CORP SEC 11,954 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2024 Thomas Samuel McClenahan EVP, GEN COUNSEL & CORP SEC 36,747 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.7 per share 4,729,338.90

Masimo Corp. in the News